Skip to main content

RDY 399 Pill - pink black capsule/oblong, 19mm

Pill with imprint RDY 399 is Pink / Black, Capsule/Oblong and has been identified as Lansoprazole Delayed Release 30 mg. It is supplied by Dr. Reddy’s Laboratories Inc.

Lansoprazole is used in the treatment of Barrett's Esophagus; Duodenal Ulcer; Duodenal Ulcer Prophylaxis; GERD; Erosive Esophagitis and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 399

Lansoprazole delayed release 30 mg RDY 399
Lansoprazole delayed release 30 mg RDY 399
Lansoprazole delayed release 30 mg RDY 399
Lansoprazole delayed release 30 mg RDY 399

Lansoprazole Delayed Release

Imprint
RDY 399
Strength
30 mg
Color
Pink / Black
Size
19.00 mm
Shape
Capsule/Oblong
Availability
Rx and/or OTC
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy’s Laboratories Inc.
Inactive Ingredients
ammonia, hydroxypropyl cellulose, low substituted hydroxypropyl cellulose, magnesium carbonate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol, polysorbate 80, propylene glycol, shellac, corn starch, sucrose, raw sugar, titanium dioxide, magnesium silicate, gelatin, ferrosoferric oxide, ferric oxide red, ferric oxide yellow, sodium lauryl sulfate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
55111-0399 Dr. Reddy's Laboratories, Inc.
68084-0468 (Discontinued) Amerisource Health Services
63739-0555 McKesson Packaging Services
Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer